Fortunato Rocca
Director/Board Member at INTERPACE BIOSCIENCES, INC.
Net worth: 441 324 $ as of 2024-03-30
Profile
Fortunato Ron Rocca is currently an Independent Director at Interpace Biosciences, Inc. and a Director at Circular Genomics, Inc. Previously, he served as the President, Chief Executive Officer & Director at Exagen, Inc. from 2011 to 2022.
He also worked as a Marketing Director at Elan Pharmaceuticals LLC from 1998 to 2004 and as the Chief Operating Officer at Zoetis Products LLC from 2004 to 2005.
Additionally, he held the position of General Manager, Vice President-Sales & Marketing at Prometheus Laboratories, Inc. from 2005 to 2011.
Mr. Rocca has a background in undergraduate studies from Towson University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EXAGEN, INC.
1.61% | 2023-04-17 | 277,562 ( 1.61% ) | 441 324 $ | 2024-03-30 |
| 2023-09-14 | 0 ( -.--% ) | - $ | 2024-03-30 |
Fortunato Rocca active positions
| Companies | Position | Start |
|---|---|---|
| INTERPACE BIOSCIENCES, INC. | Director/Board Member | 2020-01-21 |
Circular Genomics, Inc.
 Circular Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Circular Genomics, Inc. is a company that specializes in the development of circular RNA-based precision medicine tools, data, and diagnostics for neurology and psychiatry. The company is based in Albuquerque, NM. The company is focused on disrupting and improving the standard of care for major depressive disorder and other neurological diseases. The company offers assays that can assess and direct the best treatment protocol for an individual patient and validate treatment effectiveness in days-to-weeks rather than months. The company was founded in 2021 by Alexander Hafez, Kosmas Karadimitriou, and Nikolaos Mellios. Paul Sargeant has been the CEO of the company since 2023. | Director/Board Member | 2023-08-16 |
Former positions of Fortunato Rocca
| Companies | Position | End |
|---|---|---|
| EXAGEN INC. | Chief Executive Officer | 2022-10-15 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Sales & Marketing | 2011-09-30 |
Zoetis Products LLC
 Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Zoetis Products LLC engaged in the manufacturing of pharmaceutical products. The company was founded in 1975 and was headquartered in Florham Park, NJ. | Chief Operating Officer | 2005-04-30 |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Sales & Marketing | 2003-12-31 |
| Alpharma LLC | Chief Executive Officer | - |
Training of Fortunato Rocca
| Towson University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INTERPACE BIOSCIENCES, INC. | Health Technology |
| EXAGEN INC. | Health Services |
| Private companies | 6 |
|---|---|
Zoetis Products LLC
Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Zoetis Products LLC engaged in the manufacturing of pharmaceutical products. The company was founded in 1975 and was headquartered in Florham Park, NJ. | Health Technology |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |
| Alpharma LLC | |
Circular Genomics, Inc.
Circular Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Circular Genomics, Inc. is a company that specializes in the development of circular RNA-based precision medicine tools, data, and diagnostics for neurology and psychiatry. The company is based in Albuquerque, NM. The company is focused on disrupting and improving the standard of care for major depressive disorder and other neurological diseases. The company offers assays that can assess and direct the best treatment protocol for an individual patient and validate treatment effectiveness in days-to-weeks rather than months. The company was founded in 2021 by Alexander Hafez, Kosmas Karadimitriou, and Nikolaos Mellios. Paul Sargeant has been the CEO of the company since 2023. | Commercial Services |
- Stock Market
- Insiders
- Fortunato Rocca
